Clinical trial
A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of…
NCT00231777 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00231777 |
|---|---|
| Title | A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015) |
| Official title | A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study Conducted Under In-House Blinding Conditions, to Examine the Safety and Tolerability of IV MK0517 for the Prevention of Postoperative Nausea and Vomiting (PONV) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post-Operative Nausea and Vomiting |
| Intervention type | Drug |
| Interventions | Comparator: MK0517, Comparator: ondansetron |
| Enrollment | 216 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 4, 2005 |
| Last update posted | Aug 19, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: